Patient characteristics | n = 1,761 (%) |
---|---|
Mean age years (SD) | 74.6 (10.4) |
Sex | |
Male | 928 (52.7%) |
Female | 833 (47.3%) |
Long-term indication for oral anticoagulation therapy | |
Atrial fibrillation/flutter | 1,415 (80.4%) |
Recurrent venous thromboembolism | 142 (8.1%) |
Recurrent pulmonary embolism | 37 (2.1%) |
Mechanical heart prosthesis | 93 (5.3%) |
Intracardiac thrombus | 10 (0.6%) |
Other indication | 22 (1.2%) |
No long-term indication | 42 (2.4) |
Antithrombotic medication* | |
Coumarin | 1,554 (88.2%) |
Dabigatran | 46 (2.6%) |
Rivaroxaban | 61 (3.5%) |
Antiplatelet therapy | 55 (3.1%) |
Other antithrombotic medication | 11 (0.6%) |
No antithrombotic medication | 34 (2%) |
Within therapeutic INR target range** | 1,013 (67.3%) |
Patient self-management | |
INR self-measuring and dose adjustment | 149 (8.5%) |
INR self-testing and dose adjustment by GP | 1 (0.1%) |
Patients with migration background | 160 (9.1%) |
Patients compliance assessed by GP | |
Very good compliance | 1,157 (65.7%) |
Good compliance | 450 (25.6%) |
Non-compliant | 129 (7.3%) |
No assessment available | 25 (1.4%) |